Probiotics: their role in the treatment and prevention of disease
- 1 April 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anti-infective Therapy
- Vol. 4 (2) , 261-275
- https://doi.org/10.1586/14787210.4.2.261
Abstract
A probiotic is a "live microbial food ingredients that, when ingested in sufficient quantities, exerts health benefits on the consumer". Probiotics exert their benefits through several mechanisms; they prevent colonization, cellular adhesion and invasion by pathogenic organisms, they have direct antimicrobial activity and they modulate the host immune response. The strongest evidence for the clinical effectiveness of probiotics has been in their use for the prevention of symptoms of lactose intolerance, treatment of acute diarrhea, attenuation of antibiotic-associated gastrointestinal side effects and the prevention and treatment of allergy manifestations. More research needs to be carried out to clarify conflicting findings on the use of probiotics for prevention of travelers' diarrhea, infections in children in daycare and dental caries, and elimination of nasal colonization with potentially pathogenic bacteria. Promising ongoing research is being conducted on the use of probiotics for the treatment of Clostridium difficile colitis, treatment of Helicobacter pylori infection, treatment of inflammatory bowel disease and prevention of relapse, treatment of irritable bowel syndrome, treatment of intestinal inflammation in cystic fibrosis patients, and prevention of necrotizing enterocolitis in premature infants. Finally, areas of future research include the use of probiotics for the treatment of rheumatoid arthritis, prevention of cancer and the treatment of graft-versus-host disease in bone marrow transplant recipients.Keywords
This publication has 136 references indexed in Scilit:
- Phenotypic Differences between Commercial Lactobacillus rhamnosus GG and L. rhamnosus Strains Recovered from BloodClinical Infectious Diseases, 2004
- Probiotics and colorectal cancer riskBritish Journal of Nutrition, 2004
- Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-Configurated ileal-pouch-anal-anastomosis (IPAA)Scandinavian Journal of Gastroenterology, 2004
- Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trialThe Lancet, 2003
- Lipoteichoic Acids fromLactobacillusStrains Elicit Strong Tumor Necrosis Factor Alpha-Inducing Activities in Macrophages through Toll-Like Receptor 2Clinical and Vaccine Immunology, 2003
- Treatment of Relapsing Clostridium difficile Diarrhea with Lactobacillus GGNutrition Today, 1996
- Lactobacillus‐ and bifidobacterium‐mediated antigenotoxicity in the colon of ratsNutrition and Cancer, 1996
- PharmacologyGut, 1996
- In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteriaJournal of Applied Bacteriology, 1995
- Effects of feeding lactobacillus GG on lethal irradiation in miceDiagnostic Microbiology and Infectious Disease, 1987